| Website | wavetecvision.com |
| Category | BioTech |
| Employees | |
| Description | cataract surgery |
| TOTAL | $52.5M |
| VENTURE FUNDING TOTAL | $52.5M |
| Series C, 2/09 | $20.1M |
| Series D, 5/11 Versant Ventures Accuitive Medical Ventures De Novo Ventures Gund Investment, LLC | $15.9M |
| Venture Round, 4/12 Accuitive Medical Ventures De Novo Ventures | $16.5M |
WaveTec Vision is a small company with a big idea – and the ability and the team to achieve it. Their proprietary intraoperative aberrometer system ORange, will transform and advance the emerging convergence of refractive and cataract surgery. For demanding patients - and the skilled surgeons who serve them - ORange delivers the potential for optimal results.